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The human cytomegalovirus major immediate-early gene encodes several protein isoforms which autoreg-
ulate the major immediate-early promoter (MIEP). One of these isoforms, the IE86 protein, represses the
MIEP through a DNA sequence located between the TATA box and the transcription initiation site, designated
the cis repression signal (crs). Through mutational analysis, amino acid domains within IE86 responsible for
binding the crs element were located at the C terminus. Mutation of the putative zinc finger domain, which
precluded IE86 from binding DNA, converted the protein from a repressor of MIEP transcription into an
activator. DNase I protection analysis demonstrated that the IE86 footprint overlapped the sequence protected
by the TATA-binding protein (TBP). Investigation of whether IE86 was able to displace TBP from DNA
revealed that both proteins could bind DNA simultaneously. However, higher concentrations of IE86 were
required to obtain protection of the crs element in the presence of prebound TBP. Similarly, higher
concentrations ofTBP were required to obtain protection in the presence ofprebound IE86. These observations
indicate that steric hinderance impairs but does not prevent both proteins from binding DNA synchronously.
The gene expression of human cytomegalovirus (HCMV)
is temporally regulated by host cell and viral proteins during
the infection cycle (9, 20, 59, 64, 65). The immediate-early
(IE) genes are the first HCMV genes expressed after infec-
tion and produce transcriptional regulatory proteins that
control subsequent viral gene expression (4, 11, 51, 53,
56-58, 60). The mechanisms of transcriptional regulation by
these proteins are not completely understood but may be
mediated by direct binding of DNA or protein-protein inter-
actions with cellular transcription factors.
The predominant IE proteins originate from two contigu-
ous regions of abundant IE expression, historically termed
IE region 1 (IE-1/UL123) (5, 55, 57) and IE region 2
(IE-2/UL122) (5, 55, 58). Since the major IE promoter
(MIEP) directs the expression of both regions, IE-1 and IE-2
constitute the major IE gene. However, within the IE2
region, an internal late promoter directs the expression of an
mRNA encoding a 40-kDa protein (LAO) with a reading frame
that overlaps those for other proteins encoded in this region
(52, 55). Alternative splicing and polyadenylation events
generate mRNAs that code for variant isoforms of an IE
protein (55, 57, 58). The three predominant IE isoforms are
phosphoproteins (15) with apparent molecular masses of 86
kDa (IE86), 72 kDa (IE72), and 55 kDa (IE55). IE72 has the
same N terminus as IE86 and IE55, while IE86 and IE55
have identical amino acid sequences except for a 154-amino-
acid deletion between amino acid residues 365 and 519 in
IE86 (Fig. 1) (55, 57, 58). Functionally, the IE isoforms are
all capable of transactivating heterologous promoters (1, 11,
14, 17, 19, 56, 61, 63), while IE72 and IE86 together
* Corresponding author.
t Publication number 7863-IMM from the Departments of Immu-
nology and Neuropharmacology, Scripps Research Institute.
demonstrate strong synergistic activity (11, 14, 17, 56, 60,
61, 63). The IE proteins also autoregulate their own pro-
moter (1, 8, 16, 32, 43, 49, 56). While IE86 represses MIEP
expression through a DNA sequence known as the cis
repression signal (crs) element (-14 to +1) (7, 29, 41), IE72
(8, 49) and IE55 (1) transactivate this promoter. Levels of
these isoforms within a cell are critical for the activity of the
MIEP and may be the ultimate determinant for the viral
permissiveness of a cell.
The IE isoform proteins contain amino acid sequences
with characteristics similar to those of other transcription
factors (2, 24, 34, 35, 47, 62). Some putative motifs include
three amphipathic helices at the N terminus of all the
isoforms, single zinc finger motifs in IE86 and IE72, a
leucine zipper in the IE72 protein, and a leucine-rich region
in the IE86 protein (Fig. 1). Each isoform also contains two
nuclear localization signals, which have been previously
described (42). Sequences within exon 3 and the C terminus
of IE86 and IE55 were found to be critical for promoter
activation (16, 32, 43, 56). Domains responsible for negative
regulation by IE86 were localized to the C terminus (29, 41,
56).
The mechanism of IE86 autorepression of the MIEP is
unclear. Other viral models of autorepression have sug-
gested that either protein-protein interactions or direct bind-
ing of a cis-responsive sequence may mediate this process
(18, 22, 36, 44, 45). Recently, the IE86 protein was shown to
bind the crs element (25). A truncated portion of this protein
closely equivalent to the LA0 protein was also able to bind
this element and induce repression in cell-free nuclear ex-
tracts (30). These observations, in combination with the
inability of the crs element to function when placed 5' to the
TATA box (7), suggest that the IE86 protein may physically
inhibit formation of the transcription initiation complex at
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FIG. 1. Schematic representation of the IE86, IE55, and IE72
proteins of HCMV. The domains shown in the diagram are the three
a helices (Hi, H2, and H3), zinc fingers (Zn), leucine-rich region
(LR), leucine zipper region (LZ), acidic region (AR), and nuclear
localization signals (NL). The exons from which each of the
domains arise are indicated together with the positions of the
restriction enzymes that were used in the construction of the IE86
mutants.
the level of the TATA box-binding protein (TBP) or other
basal transcription factors. In these studies, we demonstrate
domains within IE86 that are responsible for mediating
repression and the effect of this protein on TBP binding of
the TATA box.
MATERIALS AND METHODS
Plasmid constructions. Oligonucleotides 5'-TCCTTClGAT
CCATGGAGTCCTCTGCCAAG-3' and 5'-TCCCGAATTC
GGATC1TACTGAGACTrGTTCCTC-3' were used to
produce a fragment encoding the IE86 gene from plasmid
pIE86kd (48, 56) by polymerase chain reaction (PCR). The
BamHI sites are underlined, and the ATG and TTA codons
are shown in boldface. After this fragment was digested with
BamHI, it was cloned into vector pDS56,6His, also digested
with BamHI (27). This vector contains six codons encoding
histidine residues immediately upstream of the BamHI site.
The orientation and nucleotide sequence of the 5' and 3'
ends were confirmed by direct sequencing of the plasmid
(50). To ensure that any mutations introduced by the Taq
polymerase were eliminated, the Apal-Stul fragment encod-
ing virtually all of IE86 was subcloned back into this plasmid
to generate p86,6His.
To produce the point mutations in the putative zinc finger
of IE86, the EcoRI-HindIII fragment from plasmid pRSV86
(1), encoding part of the Rous sarcoma virus long terminal
repeat, all of IE86, and the IE2 3' untranslated region, was
subcloned into the EcoRI and HindIII sites of M13mpl9.
Oligonucleotide 5'-GCCAGGTTGaACATGGTGCCCAGI
CIA-iACCGC-3' (underlined bases are mutated from the
wild-type sequence) was used in conjunction with an oligo-
nucleotide mutagenesis kit purchased from Amersham (Ar-
lington Heights, Ill.) to mutate cysteines 428 and 434 to
serine residues. Following confirmation of the correct clone
by sequencing, an MluI-StuI fragment was subcloned back
into the expression plasmids p86,6His and pRSV86 to gen-
erate p86,6HismZn and pRSV86mZn, respectively. The
C-terminal truncations were generated by digesting p86,6His
with HindIlI and either MluI (p86,6HisAC1) or StuI (p86,
6HisAC2), filling in the ends with Klenow polymerase, and
religating the plasmids. The HindIII site and sequence
immediately downstream encodes stop codons in all three
reading frames.
The double stranded oligonucleotide 5'-aattgattaaagag
gagaaattaactATGcatcaccatcaccatcacgtggatccaagaa gg-3'
contains a PmlI site (shown in boldface) and also encodes
the sixth histidine residue of the tag. The remaining five
histidine codons are situated between the PmIl site and the
ATG codon (shown in capital letters). The oligonucleotide
also contains EcoRI- and Sall-compatible ends for cloning
into pDS56,6His to generate plasmid pDS56,6His(P). Note
that the EcoRI site originally present in the vector is not
regenerated, but a new EcoRI site (underlined) is present in
the oligonucleotide. This vector was digested with PmlI and
HindIII, and the PvuII-HindIII fragment from p86,6His was
cloned to juxtapose leucine 48 next to the six histidine
residues (p86,6HisAN1). Plasmid p55,6His was constructed
by inserting an ApaI-StuI fragment from pIE55kd(56) into
p86,6His.
The nucleotide sequence encoding human TBP was ob-
tained from pT7hD (54) by PCR with the primers 5'-TACAC
GGCACGTGGATCAGAACAACAGCCTGC-3' and 5'-AC
CTAGAATTCTTACGTCGTCTTCCTGAA-3'. This PCR
product was digested with PmlI and EcoRI (sites are indi-
cated in bold) and inserted into pDS56,6His(P) previously
digested with the same enzymes, generating expression
vector phTBP,6His, capable of expressing human TBP with
an ATG-(6 His)-Val sequence preceding the Asp at position
2 of hTBP.
Purification of recombinant proteins. Eschenchia coli
strains harboring each of the expression plasmids were
grown to an optical density at 550 nm of 0.7 to 0.8 prior to
induction with 200 ,ug of isopropyl-o-D-thiogalactopyrano-
side (IPTG) per ml. Cells were harvested after 90 to 120 min
of induction and stored at -70°C. Cells were thawed and
then lysed in buffer containing 50mM sodium phosphate (pH
7.8), 1 mM phenylmethylsulfonyl fluoride, 1% Tween 20, 1
M NaCl, and 1 mg of lysozyme per ml for 20 min prior to
sonication. Following centrifugation at 16,000 rpm in a
Sorvall SS34 rotor, the cleared lysate was subjected to Ni2"
chelate chromatography (Qiagen, Chatsworth, Calif.) over a
column equilibrated in buffer containing 50 mM sodium
phosphate (pH 7.8), 500 mM NaCl, and 10% glycerol. After
being washed with this buffer, the column was washed in a
similar buffer at pH 6.0. A final wash was performed with the
latter buffer containing 75 mM imidazol prior to elution with
the same buffer containing 500 mM imidazol. Fractions
containing each of the proteins were pooled and dialyzed
against either 50 mM sodium phosphate (pH 7.8)-250 mM
NaCl-1 mM j3-mercaptoethanol-30% glycerol or 20 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid, pH 8.0)-0.5 mM EDTA-2 mM MgCI2-1 mM f-mercap-
toethanol-50 mM KCl-30% glycerol for the HCMV IE
proteins and TBP, respectively. Purified proteins were ana-
lyzed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by Coomassie blue staining;
concentrations were then determined by the Bradford
method (Bio-Rad, Hercules, Calif.).
Mobility shift assay. The mobility shift assay was per-
formed essentially as described previously (13) except that
the assay buffer contained 25 mM Tris-HCl (pH 8.0), 0.5 mM
dithiothreitol, 0.5 mM EDTA, 6.25 mM MgCl2, 0.2 ,ug of
poly(dG)-poly(dC), 10% glycerol, and cold competitor oligo-
nucleotides where indicated, in a total volume of 25 ,ul. The
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IE86 orIE55 protein was incubated for 2 min in assay buffer
prior to the addition of 0.5 pmol of probe which had been
labeled with Sequenase (USB) and [a-32P]dATP. The incu-
bation was continued for 10 min before loading onto a 4%
polyacrylamide gel. Assay mixes which contained monoclo-
nal antibody to IE86 or gpl20 were incubated for 2 min
following the addition of probe prior to the addition of
antibody. Incubation was then continued for a further 10
min. The gel and running buffer contained 6.7 mM Tris-HCl
(pH 7.3), 3.3 mM sodium acetate, and 1 mM EDTA. Fol-
lowing electrophoresis, the gel was dried and autoradio-
graphed.
Cell culture and transfection assays. Transfections were
performed by the calcium phosphate precipitation method
on monolayers of cells which were approximately 80%
confluent. In each case, the total amount of DNA was kept
constant by the addition of Bluescript II. No effect on the
reporter plasmid was observed when it was cotransfected
with just Bluescript II. Cells were harvested and assayed for
chloramphenicol acetyltransferase (CAT) activity as de-
scribed previously (38). Briefly, for each assay, 100,g of
protein was assayed for CAT activity by measuring the
amount of [3H]acetyl coenzyme A label transferred to chlor-
amphenicol. The reaction mix contained 25 mM Tris-HCl
(pH 7.8), 3 mM chloramphenicol, 100p,M cold acetyl coen-
zyme A, and 0.2 p,Ci (5 PM) of [3Hlacetyl coenzyme A.
Following addition of the protein extract, 3 ml of Econofluor
2 (New England Nuclear, Boston, Mass.) was added. At
increasing time intervals, the reaction was monitored by
scintillation counting, and the linear range was determined,
at which point the fold induction was calculated. Each
experiment was repeated at least three times, from which an
average and standard deviation were determined.
DNase I protection analysis. The DNase I protection anal-
ysis was performed essentially as described previously (12).
Briefly, the assay buffer contained 25 mM Tris-HCl (pH 8.0),
0.5 mM dithiothreitol, 0.5 mM EDTA, 6.25 mM MgCl2, 0.2
p,g of poly(dG)-poly(DC), 10% glycerol, and cold competitor
oligonucleotides where indicated, in a total volume of 25 ,ul.
Recombinant IE86, TBP, or bovine serum albumin (BSA)
was incubated for 2 min in assay buffer prior to the addition
of probe which had been labeled with [a-32P]ATP on either
the top- or bottom-strand oligonucleotide before annealing
with the complementary cold oligonucleotide. After a further
10-min incubation, 1 U of DNase I was added, and the
incubation was continued for 90 s, at which time the reaction
was stopped with the addition of 100 PIu of 200 mM NaCl-1%
SDS-20 mM EDTA-50 p,g of tRNA per ml-2.5 p,g of
proteinase K per ml. Following a further 10-min incubation
at 37°C, the samples were extracted with phenol and chlo-
roform before being loaded on a 12% denaturing polyacryl-
amide gel. In the experiments with both IE86 and TBP,
either IE86 or TBP was allowed to bind the probe for 5 min
prior to the addition of the remaining protein, at which time
the incubation was continued for 10 min before addition of
the DNase I. Subsequently, the gel was dried and the
protection patterns were visualized by autoradiography.
Oligonucleotides. The following oligonucleotides were syn-
thesized on a Gene Assembler Plus (Pharmacia LKB): -35
to +4 MIEP, (top) 5'-AGCTTGAGGTCTATATAAGCA
GAGCTCG'Tfl'l'AGTGAACCGTCAG-3' and (bottom) 5'-
GATCCTGACGGTTCACTAAACGAGCTCTGCTlATAT
AGACCTCA-3'; -35 to +18 MIEP, (top) 5'-AGCTl'lGAGG
TCTATATAAGCAGAGCTCG'TTTAGTGAACCGTCA
GATCGCCTGGAGACG-3' and (bottom) 5'-GATCCGTC
TCCAGGCGATGTACGGTTCACTAAACGAGCTCTGC
TTATATAGACCTCA-3'; -35 to +4 (m2crs) MIEP, (top)
5'-AGCTTGAGGTCTATATAAGCAGAGCTCAAAGGC
CTGTACGTCAG-3' and (bottom) 5'-GATCCTGACGTAC
AGGCCTTTGAGCTCTGCITrATATAGACCTCA-3'; -35
to +18 (mcrs) MIEP, (top) 5'-AGCTTGAGGTCTATATAA
GCAGAGCTGCGGCGTGTCCACGTCAGATCGCCTG
GAGACG-3' and (bottom) 5'-GATCCGTCTCCAGGCGAT
CTGACGTGGACACGCCGCAGCTCTGCTTATATAGA
CCTCA-3'; -35 to +18 (m3crs) MIEP, (top) 5'-AGCTTGA
GGTCTATATAAGCAGAGCTCGTCTAGTGAACCGT
CAGATCGCCTGGAGACG-3' and (bottom) 5'-GATCCGT
CTCCAGGCGATGTACGGTTCACTAGACGAGCTCT
GCTTATATAGACCTCA-3'; and the USF binding site oli-
gonucleotide, (top) 5'-AGCTTAGCATI"TCATCACATGG
CCCGAGA-3' and (bottom) 5'-TCGTAAAGTAGTGTACC
GGGCTCT-lCGA-3'. The oligonucleotides were subjected
to denaturing preparative PAGE with 12% polyacrylamide.
The oligonucleotides were visualized by low-power UV (210
nm) shadowing on photocopying paper, and full-length prod-
uct was excised from the gel and electroeluted into lx TBE
(90 mM Tris-borate and 2 mM EDTA) buffer.
RESULTS
Binding of EE86 to the crs element. To examine the ability
of IE86 to bind to the crs element, the gene encoding IE86
was expressed in E. coli under the control of an IPTG-
inducible promoter. To facilitate purification, a short linker
sequence encoding six histidine residues was cloned onto the
5' end of the IE86 cDNA (Fig. 2B). Under nondenaturing
conditions, IE86 was purified to approximately 90% homo-
geneity by nickel chelate chromatography (Fig. 2A, lane 1).
A similar methodology using denaturing conditions has been
described previously (25). To identify the domain responsi-
ble for contacting DNA, a variety of mutant IE86 proteins
were constructed (Fig. 2B) and purified (Fig. 2A, lanes 2 to
5). In addition, the gene encoding IE55 was expressed and
purified to a similar homogeneity from E. coli (data not
shown). Initially, binding of IE86 to a labeled probe whose
sequence corresponded to that of the MIEP from -35 to +4
was examined in a mobility shift assay (Fig. 3A, lane 5).
Although highly pure IE86 protein was used, a monoclonal
antibody that recognized an epitope encoded within exon 2/3
was used to supershift the IE86 nucleoprotein complex to
show that IE86 was indeed part of this complex (Fig. 3A,
lane 7). A supershift was not observed with a monoclonal
antibody directed against the gpl20 envelope protein of
human immunodeficiency virus (Fig. 3A, lane 6). The probe
was not shifted with either antibody in the absence of IE86
(data not shown). In addition, a second probe whose se-
quence corresponded to that of the MIEP from -35 to +18
was also used in some of the mobility shift experiments.
Binding of IE86 to this probe was identical to that of the
previous probe (Fig. 3B, lane 2).
To show the specificity of binding, various competition
experiments were performed with a 50-fold excess of a
variety of different unlabeled probes. Competition was ini-
tially performed with a cold excess of the -35/+4 and
-35/+18 MIEP probes. Under these conditions, no nucleo-
protein complexes were observed between either the shorter
or the longer labeled probe and IE86 (Fig. 3A, lane 8, and
Fig. 3B, lane 3, respectively). By contrast, competition with
excess probe containing a series of clustered point mutations
in the crs element, -35/+18 (mcrs) MIEP, that had previ-
ously been shown to eliminate repression of MIEP transcrip-
tion by IE86 in vivo (1, 7), did not abrogate the formation of
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FIG. 2. Wild-type and mutant forms of IE86. (A) Coomassie-stained gel showing wild-type and mutant IE86 proteins following dialysis of
the pooled fractions after nickel chelate chromatography. Lane 1, 250 ng of wild type IE86; lanes 2 to 5 correspond to the mutant forms IE86
mZn, IE86AN1, IE86AC1, and IE86AC2, respectively. (B) Schematic diagrams of the wild-type and mutant IE86 proteins. The position of the
first ATG codon (encoding methionine) preceding the six-histidine tag (shaded box) is shown. The restriction sites in the IE86 cDNA used
in the construction of the mutant proteins are indicated together with the residues in IE86 that were changed to destroy the putative zinc
finger.
the nucleoprotein complex between the shorter or longer
labeled MIEP probes (Fig. 3A, lane 9, and Fig. 3B, lane 4,
respectively). In addition, an excess of another mutation in
the crs element, in the probe designated m2crs, which had
the following changes in the context of the shorter probe,
CTCGTIITAGTGAACCG to CTCAAAGGCCTGTACG
(the underlined nucleotides were mutated), did not affect the
binding of the longer MIEP probe to IE86 (Fig. 3B, lane 5).
An excess of a cold probe whose sequence corresponded to
the binding site of USF did not compete for the binding of
the shorter or longer labeled probe to IE86 (Fig. 3A, lane 10,
and Fig. 3B, lane 6, respectively).
To delineate the domain in IE86 responsible for the
binding of IE86 to DNA, various mutant proteins were
A.
Ab Competition
m---l I -I
Protein - AC1 MZn AN1 86 86 86 86 86 86
examined. A deletion in the N terminus of IE86 (IE86AN1)
did not affect the ability of the protein to bind DNA (Fig. 3A,
lane 4, and Fig. 3B, lane 9). Moreover, a protein expressing
the N terminus alone, mutant IE86AC1, was ineffective at
binding probe (Fig. 3A, lane 2). The C-terminal half of the
IE86 protein contains a number of putative domains, includ-
ing a zinc finger, a leucine-rich region, and an acidic region
(37, 56, 58). The IE55 isoform, which is identical to the IE86
protein except for a 154-amino-acid deletion between amino
acid residues 365 and 519 of IE86, has previously been
shown to be unable to repress the MIEP in vivo (1). The
domains absent in the IE55 protein include the putative zinc
finger and the leucine-rich region but not the acidic region at
the extreme C terminus (Fig. 1). Therefore, we hypothesized
B.
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FIG. 3. Mobility shift assay showing the direct binding of IE86 to the crs element. Where included, the total IE (wild-type or mutant)
protein concentration was 250 nM. (A) The -35/+4 MIEP oligonucleotide fragment (0.5 pmol) was used as a probe in lanes 1 to 10. Additions:
lane 2, IE86AC1 (AdCl); lane 3, IE86 mZn (mZn); lane 4, IE86AN1 (ANl); lanes 5 to 10, IE86 wild type (86). Lanes 6 and 7 also contained
monoclonal antibody (40 FLg/ml) to IE86 and gpl20 (from human immunodeficiency virus), respectively. The shifted (86 and 86AN1) and
supershifted (Ab:86) complexes are indicated. Competition analysis was performed in lanes 8 to 10 by the inclusion of a 50-fold excess of cold
-35/+4 MIEP, -35/+18 (mcrs) MIEP, or USF-binding site oligonucleotide, respectively. (B) The -35/+18 MIEP oligonucleotide fragment
(0.5 pmol) was used as a probe in lanes 1 to 10. Additions: lanes 2 to 6, IE86; lane 7, IE86AC2 (AC2); lane 8, IE86AC1 (AC1); lane 9, IE86AN1
(ANi); lane 10, IE55. For the competition analysis, lanes 3 to 6 also contained a 50-fold excess of cold -35/+18 MIEP, -35/+18 (mcrs) MIEP,
-35/+18 (m2crs) MIEP, or USF-binding site oligonucleotide, respectively. The shifted (86 and 86AN1) complexes are indicated.
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FIG. 4. Activation and repression of the MIEP by wild-type and mutant forms of IE86. The fold induction produced by either IE86 or IE86
mZn compared with basal promoter levels is shown. Permissive U373-MG cells were transfected with 1 ,ug of pMIEP(-1145/+112)CAT (A)
or pMIEP(mcrs)CAT (B). The quantity (in micrograms) of the effector plasmids RSV86 and RSV86 mZn is indicated. The results were
calculated in the linear range of the assay after 20 to 30% of the substrate had been converted and are the averages of at least three independent
experiments; the error bars indicate the standard deviation. Schematics of the reporter plasmids pMIEP(-1145/+112)CAT and pMIEP
(mcrs)CAT are also shown.
that the putative zinc finger might be responsible for medi-
ating the binding of IE86 to DNA, since similar structures
have been shown to be critical for the binding of other
transcription factors (2, 21, 35) as well as hormones (31) to
DNA. Therefore, mutations were made in the putative zinc
finger of IE86 which changed the cysteine residues at posi-
tions 428 and 434 to serine residues. Nucleoprotein complex
formation was not detected with the IE86 mZn protein in the
gel mobility shift assay (Fig. 3A, lane 3).
Therefore, the putative zinc finger is important for DNA
binding. Examination of the literature, however, revealed
that deletion of the acidic C-terminal domain of IE86 from
amino acids 542 to 579 eliminated the ability of IE86 to
negatively regulate the MIEP in vivo (43). To determine
whether this mutation abrogated the ability of IE86 to bind
DNA, we analyzed the IE86AC2 mutant (Fig. 2) in a mobility
shift assay. Nucleoprotein complex formation was not de-
tected with this mutant protein and the crs probe (Fig. 3B,
lane 7). From these data, the region of IE86 responsible for
contacting DNA would appear to be more extensive and not
restricted to the putative zinc finger domain. Alternatively,
the C-terminal domain could be solely responsible for medi-
ating the binding of IE86 to DNA, and disruption of such an
important structural component as a zinc finger may have
caused more extensive perturbations in the overall configu-
ration of the protein that would contribute to its nonfunc-
tionality. Therefore, the naturally occurring IESS isoform of
the IE86 protein described above, which lacks the putative
zinc finger but has an intact C-terminal acidic region, was
examined for its ability to bind DNA. As shown in Fig. 3B,
lane 10, no nucleoprotein complex formation was observed
between IESS and probe. Therefore, the C-terminal acidic
domain cannot bind DNA in the absence of the putative zinc
finger and/or possibly the leucine-rich domain. Thus, the
inability of IESS to repress transcription from the MIEP in
vivo (1) is probably a direct result of the protein's inability to
bind DNA.
In vivo activation but not repression by mutant IE86. As
described above, IE86 mZn was unable to bind the probe in
a mobility shift assay. To examine whether this was the
result of a specific knockout of the putative zinc finger and
not of a general disruption of the structure of the protein, we
tested the ability of this mutant to function in vivo in a cell
line permissive for HCMV infection. All of the effector
plasmids shown in Fig. 4 produced proteins without the
six-histidine tag at their N terminus. Expression of the same
proteins with six-histidine tags yielded no difference in their
ability to transactivate or repress transcription (data not
shown). In the first experiment, shown in Fig. 4A, a con-
struct containing the MIEP, including the upstream en-
hancer and modulator sequences driving the expression of
the CAT gene, was used as the target reporter plasmid to
detect transactivation or repressive functions of the HCMV
IE86 protein. IE86 specifically repressed transcription of the
MIEP(-1145/+112)CAT reporter plasmid by 0.4-fold (Fig.
4A). Cotransfection of more IE86 did not result in further
repression (data not shown). Greater repression was ob-
served when IE86 was transfected in the presence of IE72,
which increased the basal level of promoter activity (data not
shown). In contrast, the IE86 protein containing the knock-
out of the putative zinc finger was not only unable to repress
transcription but stimulated it by approximately sixfold (Fig.
4A).
In the second experiment, shown in Fig. 4B, the function
of wild-type and mutant IE86 proteins was examined with
the construct containing the mutated crs element [pMIEP
(mcrs)CAT]. The wild-type and zinc finger mutant IE86
proteins stimulated this reporter construct to a similar de-
gree (Fig. 4B). In this experiment, the fold induction ob-
served for both proteins was similar to that obtained with the
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FIG. 5. DNase I protection of the crs element by IE86. Lanes 1
to 5 and 6 to 10 show DNase I protection of the -35/+18 MIEP
probe (0.5 pmol) labeled on the top and bottom strands, respec-
tively. In addition, lanes 1 and 5 contain 250 nM BSA as a control
protein, lanes 2 and 7 contain 50 nM IE86, and lanes 3, 4, 5, 8, 9, and
10 contain 250 nM IE86. Lanes 4 and 9 and lanes 5 and 10 also
contain a 50-fold excess of cold
-35/+18 MIEP and -35/+4 (m2crs)
MIEP oligonucleotides, respectively. The positions of the nucle-
otides, indicated by Maxam and Gilbert sequencing of the labeled
probes, are shown relative to the transcription start site (arrow). The
protected crs element (open box) and position of the TATA box are
indicated.
MIEP(-1145/+112)CAT reporter plasmid when stimulated
with IE86 mZn (Fig. 4, compare A and B). The IE86 protein
has previously been shown to require both its N terminus
and an intact C-terminal acidic domain to be competent to
transactivate both homologous and heterologous promoters
(16, 43, 56). Since the IE86 mZn protein functions identically
to the wild-type IE86 protein in its ability to transactivate,
we conclude that mutation of the putative zinc finger did not
significantly affect other regions of the protein and was
limited to this domain.
IE86 and TBP can bind DNA simultaneously. Since IE86
binds to a site overlapping the TATA box, the binding of
IE86 to the crs element may block TBP binding or even
displace bound protein from the TATA box. Therefore, we
determined whether the binding of IE86 and TBP to DNA
was mutually exclusive. First, the binding of IE86 to the crs
element in the absence of TBP was examined. Each strand of
the
-35/+18 MIEP probe was individually labeled and used
in the DNase I protection experiments shown in Fig. 5. In
lanes 2 and 3 (top strand) and lanes 7 and 8 (bottom strand),
increasing concentrations of IE86 were used. The concen-
tration required to give complete protection was approxi-
mately 250 nM (Fig. 5, lanes 3 and 8), similar to that used in
the mobility shift assay and approximately 10-fold over that
of the probe. A similar concentration of BSA added as
control gave no protection (Fig. 5, lanes 1 and 6). To show
that this protection was specific, competition analyses were
performed with a 50-fold excess of cold probe (Fig. 5, lanes
4 and 9) and -35/+4 m2crs MIEP probe as a nonspecific
competitor (Fig. 5, lanes 5 and 10). The specific probe
competed for binding to IE86, since it eliminated the protec-
tion of the labeled probes, whereas protection persisted in
the presence of the m2crs nonspecific probe. The extent of
protection observed on the top strand was between nucle-
otide positions -18 and + 10 and on the bottom strand was
between positions -24 and +3.
Since the footprint of IE86 overlaps the TATA box,
especially on the bottom strand, we hypothesized that IE86
binding might prevent the interaction of TBP with the TATA
box. To test this hypothesis, we first investigated the binding
of TBP alone to the -35/+18 MIEP probe. We observed two
areas of protection with this probe between -31 and -15,
corresponding to protection of the TATA box, and between
-20 and -5 (data not shown). Closer examination of the
latter revealed the sequence 'T'l'AGT between -12 and -7.
This sequence was sufficiently similar to a TATA box to
behave as a cryptic binding site for TBP. Since this sequence
constitutes a large portion of the crs element, this probe
could not be used to test the hypothesis that IE86 might be
able to abrogate the binding of TBP to the TATA box.
Therefore, a mutation in this sequence was introduced which
changed the T at position -11 to a C (T'TAGT to TCTAGT)
in the context of the -35/+18 MIEP probe (to generate
-35/+18 m3crs MIEP), eliminating this cryptic site. Since
this substitution was in the crs element, we first determined
whether the binding of IE86 to the -35/+18 m3crs MIEP
probe was different from that of the wild-type probe. These
data are shown in Fig. 6A. Identical protection of this probe
was observed with the same concentration of IE86 that
yielded complete protection of the wild-type probe (Fig. 6A,
lanes 3 and 7). The probe was not protected in the presence
of BSA (Fig. 6A, lanes 1 and 5) or when a 50-fold excess of
cold probe was added (Fig. 6A, lanes 4 and 8), indicating that
the protection was specific.
Incubation of the -35/+18 m3crs probe with 50 nM TBP
followed by DNase I digestion provided approximately 15 to
20 bp of protection around the TATA box (Fig. 6B, lanes 2
and 6). The result of increasing the concentration of IE86
following incubation of the probe with 50 nM TBP is shown
in Fig. 6B, lanes 3 and 4 (top strand) and lanes 7 and 8
(bottom strand). For complete protection of the top strand in
the presence of TBP, at least 500 nM IE86 was routinely
required. The bottom strand normally required 250 nM IE86
for complete protection of the crs element while maintaining
TBP protection over the TATA box. However, in some
experiments, 500 nM of IE86 was required for complete
protection of the crs element in the presence of TBP (data
not shown). In a reciprocal experiment, increasing concen-
trations of TBP were added to the probe following incuba-
tion with IE86. Under these conditions, both sites could be
protected simultaneously, although higher concentrations of
TBP were required to show protection of the TATA box in
the presence of prebound IE86 (data not shown). In addition,
we also observed in these experiments and in a mobility shift
assay (unpublished observations) that IE86 stabilized the
binding of TBP to DNA.
To show that the simultaneous protection of both the
TATA box and the crs element was specific, we repeated the
experiment in Fig. 6B with the putative zinc finger mutant of
IE86, which was shown above to be unable to bind DNA and
yet was fully competent to act as a transcriptional activator
in vivo (Fig. 4A). Shown in Fig. 7, lanes 2 and 6, is the
protection pattern obtained in the presence of TBP alone.
Addition of IE86 mZn resulted in no significant protection of
the crs element even at a concentration of 1 ALM (Fig. 7, lanes
4 and 8). In addition, inclusion of the IE86 zinc mutant was
frequently observed to enhance the binding of TBP, espe-
cially at lower concentrations of TBP (data not shown).
Thus, IE86 and TBP are clearly able to bind to their
respective sequence elements simultaneously, although
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FIG. 6. DNase I protection analysis of the crs element and the TATA box by IE86 and TBP simultaneously. Lanes 1 to 4 and 5 to 8 show
DNase I protection of the -35/+18 (m3crs) MIEP probe (0.5 pmol) labeled on the top and bottom strands, respectively. Lanes 1 and 5 are
controls showing protection in the presence of 250 nM BSA. (A) Lanes 2 and 6 contain 50 nM IE86. Lanes 3, 4, 7, and 8 contain 250 nM IE86.
In addition, a 50-fold excess of cold -35/+18 (m3crs) MIEP oligonucleotide was included in lanes 4 and 8. (B) Lanes 2 to 4 and 6 to 8 contain
50 nM TBP. In addition, lanes 3 and 7 contain 250 nM IE86 and lanes 4 and 8 contain 500 nM IE86 wild-type protein. The positions of the
nucleotides, indicated by Maxam and Gilbert sequencing of the labeled probes, are shown relative to the transcription start site (arrow). The
protected crs and TATA box elements (open boxes) are indicated. The shaded boxes represent the overlap in IE86 and TBP protection
patterns (when footprinted separately).
higher concentrations of IE86 or TBP were required for
synchronous binding.
DISCUSSION
We have identified funcitonal domains of the IE86 protein
of HCMV, which acts as a repressor of transcription by
binding to a specific sequence, termed the cis repression
signal (crs), located just downstream of the TATA box. We
found that IE86 could not displace the binding of human TBP
to the TATA box. Moreover, IE86 and TBP could bind their
respective elements simultaneously, although higher con-
centrations of IE86 were required, suggesting that there
might be steric constraints disrupting but not preventing
both proteins from binding DNA synchronously.
Binding of IE86 to DNA has also been recently described
by Lang and Stamminger (25), who used a similarly modified
IE86 protein purified under denaturing conditions. Macias
and Stinski (30) also demonstrated binding to the crs element
but used a C-terminal fragment (amino acids 289 to 579)
fused to the maltose-binding protein. This deletion mutant,
closely corresponding to the TA0 protein, demonstrated that
the DNA-binding domain was restricted to the C terminus, in
agreement with the work presented in this study. However,
these investigators could not address any effect that the N
terminus of IE86 might have had on binding. This aspect is
especially important, since isoforms of IE86 in addition to
IAO, such as the L55 protein (distinct from IE55), which
encompass mainly this domain (42, 52, 55), may possess
alternative functions. Macias and Stinski also reconstituted
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FIG. 7. DNase I protection of the TATA box by TBP but not the
crs element by IE86 mZn. Lanes 1 to 4 and 5 to 8 show DNase I
protection of the -35/+18 (m3crs) MIEP probe (0.5 pmol) labeled
on the top and bottom strands, respectively. Lanes 1 and 5 are
controls showing protection in the presence of 500 nM BSA. Lanes
2 to 4 and 6 to 8 contain 50 nM TBP. In addition, lanes 3 and 7
contain 500 nM IE86 mZn and lanes 4 and 8 contain 1,000 nM IE86
mZn mutant protein. The positions of the nucleotides, indicated by
Maxam and Gilbert sequencing of the labeled probes, are shown
relative to the transcription start site (arrow). The open boxes show
the protection provided by TBP. The position of the crs element is
also indicated.
A.
+10 - A
+1 -1
cn
U
-10-
-20 -
-30 -
VOL. 67, 1993 5601
 o
n
 M
arch 2, 2014 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
5602 JUPP ET AL.
IE86-mediated repression of MIEP transcription in a HeLa
cell nuclear extract with their C-terminal IE86 fusion pro-
tein. Mutation of the zinc finger in this fusion protein
destroyed any ability to repress transcription. We also
investigated the effect on transcription from the MIEP by an
IE86 protein containing a similar mutation in the putative
zinc finger in vivo. Mutation of this amino acid motif
converted the function of the IE86 protein from a repressor
to an activator of MIEP transcription. This experiment not
only demonstrates the integrity of this mutant but also shows
the importance of the putative zinc finger in mediating
repression in vivo. In addition to the putative zinc finger, we
also observed that the acidic C-terminal region was impor-
tant for binding the crs element in vitro, explaining the
inability of this mutant to function in vivo (43). Therefore, it
remains to be determined which domain within this region of
IE86 contacts DNA and whether this occurs through a
previously defined protein fold, such as a zinc finger, or via
a distinct protein motif.
The footprint we observed for IE86 in the DNase I
protection experiments was identical to that obtained by
Lang and Stamminger with their IE86 (25). Since the IE86
footprint overlaps sequences which have been shown previ-
ously to be protected by TBP (6, 26, 40, 54), we examined
the possibility that binding of IE86 and TBP to their respec-
tive elements might be mutually exclusive. The footprint
obtained for TBP alone was similar to that described previ-
ously (6, 26, 40, 54). Complete protection of the probe by
IE86 or TBP frequently required a higher concentration of
protein if either TBP or IE86, respectively, had been bound
first. Thus, TBP and IE86 could impair but not prevent the
binding of the other protein to DNA. Binding of TBP, the
DNA-contacting domain of the general transcription factor
IID (TFIID), to the TATA box is the first step in the
formation of a competent preinitiation complex on class II
promoters. This interaction serves as a nucleation site for
other basal transcription factors, including TFIIB, which
interacts downstream of TBP, prior to the recruitment of
RNA polymerase II (RNAP II). Thus, we predict that IE86
inhibits the recruitment of TFIIB into the preinitiation com-
plex. However, since both TBP and IE86 were observed to
bind the promoter simultaneously, IE86 must abrogate fur-
ther assembly or elongation of RNAP II. Determination of
whether these data reflect the mechanism in vivo where TBP
is present within the much larger multisubunit complex of
TFIID requires the application of techniques that are not yet
available. However, since TFIID is much larger than TBP,
we would predict that any steric hindrance from IE86
affecting TBP binding would be enhanced by substitution of
TBP with TFIID. Therefore, the relative molarities of IE86
and TFIID within the cell may also be critical determinants
of MIEP activity.
The IE protein ICP4 of herpes simplex virus has been
shown to autoregulate its promoter by binding to a specific
sequence located between the TATA box and the mRNA
cap site, as well as transactivate early promoters (22, 45).
Therefore, the function of IE86 closely parallels that of
ICP4. In addition, the papillomavirus E2 gene product and
the adenovirus Ela protein have also been shown to both
transactivate and repress transcription (3, 18, 28, 33). In
contrast to IE86, the E2 product, although requiring a
specific sequence element, will function in cis in an orienta-
tion- and position-independent manner. Interestingly, the E2
gene product, in addition to negatively autoregulating ex-
pression of its own promoter (18), has been shown to repress
transcription of the E6 and E7 gene products through similar
sequence motifs (46). This raises the intriguing question of
whether IE86 might perform a parallel function in HCMV. A
search of the HCMV genome for sequences identical to the
crs element (taken as -14 to +1) proved negative (7).
However, the sequence that was used to search the HCMV
genome may not have been the minimum sequence neces-
sary to allow binding of IE86. Moreover, some mutations,
such as that present in the -35/+18 (m3crs) MIEP sequence,
still permitted binding. Further analysis of the sequence-
binding specificity of IE86 is required to determine whether
there are other sites in the HCMV genome at which IE86
could influence transcription.
Since the MIEP drives the expression of a single precursor
mRNA, the virus has the ability to "cassette" various
protein domains together by differential splicing of the
precursor. This results in the formation of IE86, IE55, and
IE72 as well as several uncharacterized proteins (55, 56). In
addition, differential splicing also provides the virus with a
further control mechanism by which it can channel the
processing of the precursor from one mRNA transcript
(encoding an activator) to another (encoding a repressor, for
example). The ability of HCMV to cassette protein domains
together is by no means unusual; indeed, many other viruses
utilize a similar editing procedure. For example, the E2 gene
of papillomavirus undergoes differential splicing to encode
two products, the 48-kDa transactivator and the 28-kDa
repressor (23, 33). Similarly, the Ela protein exists in two
isoforms as a result of differential splicing of its precursor
mRNA (39). In the longer 13s form, the activation domain is
dominant over the domain responsible for mediating repres-
sion, whereas the shorter 12s form lacks part of the N-ter-
minal domain responsible for mediating activation and there-
fore functions as a repressor. Interestingly, this is in contrast
to IE86, in which the repressive domain is dominant over the
activation domain. The results presented herein thus dem-
onstrate some of the piquant features of the major IE
proteins, especially IE86, and further emphasize their im-
portance in regulating the transcription of the HCMV ge-
nome.
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